Position in GSK
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$9,579,492
-$482,251 QoQ
Shares Held
182,745
+0.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#110
of 1,033 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GRIMES & Co WEALTH MANAGEMENT, LLC holds $182,377,413 across 13 Drug Manufacturers - General names. GSK ranks #8 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
120,363 | $30,568,591 | |
| 2 | AMGN |
Amgen Inc
|
80,582 | $29,180,353 | |
| 3 | ABBV |
AbbVie Inc.
|
103,634 | $26,078,458 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
370,909 | $21,371,776 | |
| 5 | PFE |
Pfizer Inc
|
805,088 | $19,386,518 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
137,963 | $17,430,244 | |
| 7 | LLY |
ELI LILLY & Co
|
8,232 | $9,873,708 | |
| 8 | GSK |
GSK plc
This page
|
182,745 | $9,579,492 |
All Filings in GSK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,579,492 | 182,745 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $10,061,743 | 182,311 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $9,100,058 | 185,564 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $8,473,171 | 196,320 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $7,735,756 | 201,452 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $6,055,410 | 156,309 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $4,730,572 | 139,875 | Shares | Sole | 2025-01-21 | |
| No filing history on record for this holder in this stock. | ||||||